Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A dataset of spatially resolved transcriptomics of post-natal cardiac development in mice

ABSTRACT: A dataset of spatially resolved transcriptomics of post-natal cardiac development in mice

PROVIDER: PRJNA1270820 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR33790085_1.fastq.gz	Fastqsanger.gz
	SRR33790085_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

A dataset of spatially resolved transcriptomics of post-natal cardiac development in mice

Project description:The post-natal development and maturation of the mammalian heart involve highly intricate processes that remain incompletely understood, particularly concerning the molecular signature and roles of the diverse cell types involved. In this study, we present a comprehensive dataset generated from murine hearts at three key post-natal developmental stages using Spatio-temporal Enhanced Resolution Omics-Sequencing (Stereo-seq), an advanced spatially resolved transcriptomic technology. This dataset encompasses spatial transcriptomes of approximately 0.186 million individual cells within intact sections of murine hearts at post-natal developmental stages. Our dataset serves as a valuable resource for investigating the mechanisms underlying mammalian heart development and maturation. Through initial analyses, we identified distinct cell types and their spatial distributions, including 93,826 cardiomyocytes within a single heart section. This extensive dataset provides researchers with opportunities for data mining and facilitates diverse analyses, including studies on transcriptional regulation, cell-to-cell communication, and the functional activities of genes and signalling molecules during critical phases of heart development.

2025-06-10 | GSE298650 | GEO

Spatially resolved multiomics of human cardiac niches - Visium

Project description:Spatially resolved multiomics of human cardiac niches - Visium

| PRJEB62497 | ENA

Spatially resolved multiomics of human cardiac niches - Multiome GEX

Project description:Spatially resolved multiomics of human cardiac niches - Multiome GEX

| PRJEB61891 | ENA

Spatially resolved multiomics of human cardiac niches - Multiome ATAC

Project description:Spatially resolved multiomics of human cardiac niches - Multiome ATAC

| PRJEB61895 | ENA

Spatially resolved epigenomic profiling of single cells in complex tissues

Project description:The recent development of spatial omics enables single-cell profiling of the transcriptome and the 3D organization of the genome in a spatially resolved manner. A spatial epigenomics method would expand the repertoire of spatial omics tools and accelerate our understanding of the spatial regulation of cellular processes and tissue functions. Here, we developed an imaging approach for spatially resolved profiling of epigenetic modifications in single cells

2022-12-16 | GSE191069 | GEO

High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq

Project description:Understanding the spatial distribution of T cells is pivotal to decrypting immune dysfunction in cancer. Current spatially resolved transcriptomics fall short in directly annotating T cell receptors (TCRs), limiting the comprehension of anti-cancer immunity. We introduce a novel technology, Spatially Resolved T Cell Receptor Sequencing (SPTCR-seq), integrating target enrichment and long-read sequencing for highly sensitive TCR sequencing. This approach yields an on-target rate of ~85%, and via a bespoke computational pipeline, it provides meticulous spatial mapping, error correction, and UMI refinement. SPTCR-seq outperforms PCR-based methods, offering superior reconstruction of the complete TCR architecture, inclusive of V, D, J regions and the vital complementarity-determining region 3 (CDR3). Applying SPTCR-seq, we reveal local T cell diversity, clonal expansion, and transcriptional evolution across spatially distinct niches in glioblastoma, identifying critical involvement of NK and B cells in spatial T cell adaptation. SPTCR-seq, by bridging spatially resolved omics and TCR sequencing, stands as a robust tool for exploring T cell dysfunction in cancers and beyond.

2023-07-25 | GSE238071 | GEO

Spatially resolved m6A profiling using m6A-ARTR-DBiT

Project description:Spatially resolved m6A profiling using m6A-ARTR-DBiT

| PRJNA1202190 | ENA

Spatially Resolved Insights Into Fistulating Crohn’s Disease Pathogenesis

Project description:Spatially Resolved Insights Into Fistulating Crohn’s Disease Pathogenesis

| PRJNA1198037 | ENA

CBTi-seq profiling spatially resolved single-cell transcriptomics in mouse brain functional areas

Project description:To evaluate the potential utility of the CBTi-seq for spatially resolved transcriptomics tissue analysis, we performed a proof-of-concept experiment by microneedle sampling and analyzing three typical mouse brain regions (cerebral cortex (Ccx), corpus callosum (Cc), and hippocampus (Hi)) under the specific zone. CBTi-seq enables spatially resolved transcriptomics analysis in the tissue microenvironment, and holds great potential for revealing the spatial and temporal characteristics and functional heterogeneity of cells.

2026-01-01 | GSE304005 | GEO

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Project description:Pancreatic ductal adenocarcinoma (PDAC) exhibits profound molecular heterogeneity and poor prognosis, necessitating novel tailored therapies. The basal and classical subtypes - driven by glycolysis versus lipid metabolism - have distinct prognostic implications. We mapped PDAC molecular subtype heterogeneity, capturing spatially-resolved gene expression signatures and generating a comprehensive high-resolution dataset of 42,035 spatial spots. Subtype assignments were validated via multiplex immunofluorescence and quantitative analyses in patient-derived organoids. Our analysis resolved cancer cell signatures, deconvoluted intra-tumoral heterogeneity, and delineated a classical-to-basal trajectory. We identified metabolically ‘hot’, high-grade tumor niches characterized by concurrent enrichment of glycolysis and lipogenesis across both subtypes, nominating them as subtype-agnostic therapeutic targets. Preclinical models demonstrated that despite the basal subtype’s glycolysis dependence, both classical and basal tumors are susceptible to glycolysis inhibition. This work challenges the dogma of subtype-specific therapeutic silos and demonstrates highly adaptable energetic niches as reservoirs to drive tumor progression.

2026-04-22 | GSE316631 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data